PT1071418E - Novos tratamentos de patologias nervosas - Google Patents

Novos tratamentos de patologias nervosas

Info

Publication number
PT1071418E
PT1071418E PT99918423T PT99918423T PT1071418E PT 1071418 E PT1071418 E PT 1071418E PT 99918423 T PT99918423 T PT 99918423T PT 99918423 T PT99918423 T PT 99918423T PT 1071418 E PT1071418 E PT 1071418E
Authority
PT
Portugal
Prior art keywords
new treatments
pathologies
nervous
reboxetine
nervous pathologies
Prior art date
Application number
PT99918423T
Other languages
English (en)
Inventor
Philip F Von Voigtlander
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Erik Ho Fong Wong
Original Assignee
Upjohn Co
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Pharmacia Italia Spa filed Critical Upjohn Co
Publication of PT1071418E publication Critical patent/PT1071418E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT99918423T 1998-04-13 1999-04-02 Novos tratamentos de patologias nervosas PT1071418E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11

Publications (1)

Publication Number Publication Date
PT1071418E true PT1071418E (pt) 2004-12-31

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99918423T PT1071418E (pt) 1998-04-13 1999-04-02 Novos tratamentos de patologias nervosas

Country Status (25)

Country Link
US (1) US6391876B1 (pt)
EP (1) EP1071418B1 (pt)
JP (1) JP2002511408A (pt)
KR (1) KR100555279B1 (pt)
CN (1) CN1197569C (pt)
AT (1) ATE277617T1 (pt)
AU (1) AU755612B2 (pt)
BR (1) BR9909476A (pt)
CA (1) CA2320722A1 (pt)
DE (1) DE69920679T2 (pt)
DK (1) DK1071418T3 (pt)
EA (1) EA003546B1 (pt)
ES (1) ES2228035T3 (pt)
HU (1) HUP0101748A3 (pt)
IL (1) IL138887A0 (pt)
IT (1) IT1305322B1 (pt)
NO (1) NO20005131D0 (pt)
NZ (1) NZ507693A (pt)
PL (1) PL194039B1 (pt)
PT (1) PT1071418E (pt)
SI (1) SI1071418T1 (pt)
SK (1) SK14482000A3 (pt)
TR (1) TR200002970T2 (pt)
WO (1) WO1999052518A2 (pt)
ZA (1) ZA200004480B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
EP1500395B1 (en) * 1999-07-01 2006-03-08 Pharmacia & Upjohn Company LLC Reboxetine for treating fibromyalgia and other somatoform disorders
PT1632234E (pt) 1999-07-01 2007-07-09 Pharmacia & Upjohn Co Llc (s,s)-reboxetina para o tratamento da síndrome de fadiga crónica
CA2426069A1 (en) * 2000-11-15 2002-05-23 David Michelson Treatment of anxiety disorders
BR0311878A (pt) * 2002-06-17 2005-04-05 Pharmacia Italia Spa Sais farmacêuticos de reboxetina
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
EP0919234A3 (en) 1997-10-17 1999-08-25 Eli Lilly And Company Potentiation of pharmaceuticals by moxonidine

Also Published As

Publication number Publication date
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
JP2002511408A (ja) 2002-04-16
TR200002970T2 (tr) 2001-01-22
DE69920679D1 (de) 2004-11-04
DK1071418T3 (da) 2005-01-03
PL194039B1 (pl) 2007-04-30
CN1293569A (zh) 2001-05-02
HUP0101748A3 (en) 2001-12-28
NO20005131L (no) 2000-10-12
KR100555279B1 (ko) 2006-03-03
DE69920679T2 (de) 2006-03-02
EA200001058A1 (ru) 2001-04-23
AU3635199A (en) 1999-11-01
CA2320722A1 (en) 1999-10-21
NZ507693A (en) 2003-08-29
US6391876B1 (en) 2002-05-21
ITMI980870A1 (it) 1999-10-23
CN1197569C (zh) 2005-04-20
EA003546B1 (ru) 2003-06-26
SI1071418T1 (en) 2005-04-30
NO20005131D0 (no) 2000-10-12
SK14482000A3 (sk) 2001-08-06
WO1999052518A3 (en) 1999-12-02
BR9909476A (pt) 2000-12-19
ES2228035T3 (es) 2005-04-01
WO1999052518A2 (en) 1999-10-21
EP1071418B1 (en) 2004-09-29
EP1071418A2 (en) 2001-01-31
IL138887A0 (en) 2001-11-25
AU755612B2 (en) 2002-12-19
ATE277617T1 (de) 2004-10-15
PL346294A1 (en) 2002-01-28
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
UA43385C2 (uk) Спосіб лікування синдрому дефіциту уваги/гіперактивності
PT1071418E (pt) Novos tratamentos de patologias nervosas
BR9914968B1 (pt) método para tratar fibras celulósicas para remover compostos não-celulósicos.
MY134110A (en) Combinations of reboxetine and neuroleptic agents
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
IS2130B (is) Glútamín-þíasólidíð og -pýrrólidíð og notkun þeirra sem dípeptidýlpeptíðasa IV hindrar
NO993208D0 (no) Mykt tissuepapir som har et overflateavsatt mykgj°ringsmiddel
PT739212E (pt) Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
DE50313386D1 (de) Mittelwalze eines Kalanders mit einer Tilgeranordnung
ATE318135T1 (de) Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
WO2002077198A3 (en) Methods of modulating angiogenesis
MY143278A (en) Treatment of neurotic disorders.
ES2118569T3 (es) Procedimiento para la regeneracion de un catalizador.
MY136367A (en) Treatment of cognitive failure
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
WO2002040006A3 (en) Treatment of anxiety disorders
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
ZA991638B (en) Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
RU2000131244A (ru) Способ выявления нарушений вегетативной регуляции и стадий развития нейроциркуляторной дистонии у детей и подростков
ES1040148U (es) Criba de levas
ECSP992873A (es) Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823)
DE50115630D1 (de) Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen